Keyphrases
Clinical Experience
100%
5-fluorouracil (5-FU)
100%
Pancreatic Adenocarcinoma
100%
Chemoradiotherapy
100%
Survival Rate
42%
Radiotherapy
28%
Median Overall Survival
28%
Acute Toxicity
28%
Nausea
28%
Type 1 Diabetes Mellitus (T1DM)
28%
Actuarial Survival
28%
Field Width
28%
Weight Loss
14%
Overall Survival
14%
Chemotherapy
14%
Median Survival
14%
Dehydration
14%
Survival Data
14%
Myocardial Infarction
14%
Carcinoma
14%
Concurrent Radiotherapy
14%
Grading System
14%
Radiation Dose
14%
Concurrent Chemotherapy
14%
Radiation Therapy Oncology Group
14%
Hematotoxicity
14%
Transient Ischemic Attack
14%
Total Dose
14%
Radiosensitization
14%
No Evidence of Disease
14%
Kaplan-Meier
14%
Dose Reduction
14%
Low Toxicity
14%
Ampulla
14%
Toxicity Profile
14%
Late Effects
14%
IV Fluids
14%
Efficacy-toxicity
14%
Chronic Toxicity
14%
Pancreatic Resection
14%
Recurrence Data
14%
Resectable Disease
14%
Actuarial Analysis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorouracil
100%
Pancreas Adenocarcinoma
100%
Chemoradiation Therapy
100%
Survival Rate
42%
Overall Survival
42%
Chemotherapy
42%
Diabetes Mellitus
28%
Acute Toxicity
28%
Nausea
28%
Diseases
28%
Infection
14%
Recurrent Disease
14%
Heart Infarction
14%
Carcinoma
14%
Chronic Toxicity
14%
Transient Ischemic Attack
14%